Zhu X - Search Results

1

Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study.

Bul M, Zhu X, Rannikko A, Staerman F, Valdagni R, Pickles T, Bangma CH, Roobol MJ. Bul M, et al. Among authors: zhu x. Eur Urol. 2012 Aug;62(2):195-200. doi: 10.1016/j.eururo.2012.02.002. Epub 2012 Feb 14. Eur Urol. 2012. PMID: 22342775

2

Screening for prostate cancer: have we resolved the controversy?

Zhu X, Roobol MJ, Schröder FH. Zhu X, et al. Curr Opin Support Palliat Care. 2010 Sep;4(3):121-6. doi: 10.1097/SPC.0b013e32833abc21. Curr Opin Support Palliat Care. 2010. PMID: 20489646 Review.

3

Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam.

Bul M, van Leeuwen PJ, Zhu X, Schröder FH, Roobol MJ. Bul M, et al. Among authors: zhu x. Eur Urol. 2011 Apr;59(4):498-505. doi: 10.1016/j.eururo.2011.01.001. Epub 2011 Feb 18. Eur Urol. 2011. PMID: 21334136 Free article. Clinical Trial.

4

Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam).

Zhu X, van Leeuwen PJ, Bul M, Bangma CH, Roobol MJ, Schröder FH. Zhu X, et al. Int J Cancer. 2011 Dec 15;129(12):2847-54. doi: 10.1002/ijc.25947. Epub 2011 Mar 29. Int J Cancer. 2011. PMID: 21448904

5

Updating the prostate cancer risk indicator for contemporary biopsy schemes.

Bul M, Delongchamps NB, Steyerberg EW, de la Roza G, van Leeuwen PJ, Zhu X, van Vugt HA, Haas GP, Schröder FH, Roobol MJ. Bul M, et al. Among authors: zhu x. Can J Urol. 2011 Apr;18(2):5625-9. Can J Urol. 2011. PMID: 21504651

6

Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.

Zhu X, van Leeuwen PJ, Bul M, Otto SJ, de Koning HJ, Bangma CH, Schröder FH, Roobol MJ. Zhu X, et al. Eur Urol. 2011 Aug;60(2):330-6. doi: 10.1016/j.eururo.2011.05.013. Epub 2011 May 17. Eur Urol. 2011. PMID: 21601352 Clinical Trial.

7

Towards an optimal interval for prostate cancer screening.

van Leeuwen PJ, Roobol MJ, Kranse R, Zappa M, Carlsson S, Bul M, Zhu X, Bangma CH, Schröder FH, Hugosson J. van Leeuwen PJ, et al. Among authors: zhu x. Eur Urol. 2012 Jan;61(1):171-6. doi: 10.1016/j.eururo.2011.08.002. Epub 2011 Aug 10. Eur Urol. 2012. PMID: 21840117 Clinical Trial.

8

Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.

Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH, van Leenders AG, Steyerberg EW, Schröder FH. Roobol MJ, et al. Among authors: zhu x. Eur Urol. 2012 Mar;61(3):577-83. doi: 10.1016/j.eururo.2011.11.012. Epub 2011 Nov 15. Eur Urol. 2012. PMID: 22104592

9

Risk-based prostate cancer screening.

Zhu X, Albertsen PC, Andriole GL, Roobol MJ, Schröder FH, Vickers AJ. Zhu X, et al. Eur Urol. 2012 Apr;61(4):652-61. doi: 10.1016/j.eururo.2011.11.029. Epub 2011 Nov 24. Eur Urol. 2012. PMID: 22134009 Free PMC article. Review.

10

Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality.

van Leeuwen PJ, van den Bergh RC, Wolters T, Zhu X, Bul M, Schröder FH, Bangma CH, Roobol MJ. van Leeuwen PJ, et al. Among authors: zhu x. Can J Urol. 2011 Dec;18(6):6018-24. Can J Urol. 2011. PMID: 22166329 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,418 results

Search Page

Filters